IRVINE, Calif. (AP) _ Edwards Lifesciences Corp. (EW) on Thursday reported fourth-quarter profit of $280.2 million.

On a per-share basis, the Irvine, California-based company said it had net income of $1.32. Earnings, adjusted for non-recurring costs, were $1.46 per share.

The results did not meet Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of $1.48 per share.

The medical device maker posted revenue of $1.17 billion in the period, topping Street forecasts. Nine analysts surveyed by Zacks expected $1.15 billion.

For the year, the company reported profit of $1.05 billion, or $4.93 per share. Revenue was reported as $4.35 billion.

For the current quarter ending in April, Edwards Lifesciences expects its per-share earnings to range from $1.49 to $1.59.

The company said it expects revenue in the range of $1.15 billion to $1.2 billion for the fiscal first quarter.

Edwards Lifesciences expects full-year earnings in the range of $6.15 to $6.40 per share, with revenue ranging from $4.6 billion to $5 billion.

Edwards Lifesciences shares have risen slightly since the beginning of the year, while the Standard & Poor's 500 index has climbed almost 2%. In the final minutes of trading on Thursday, shares hit $234.13, a climb of 39% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EW at https://www.zacks.com/ap/EW

Automated Insights, source Associated Press News